Single Blood Drop Analysis: Technologies and Global Market
![](/report_cover/10349/single-blood-drop-analysis-technologies-n-global-market_en.gif)
REPORT SCOPE:
The scope of this study entails the current market for blood analyzers, especially the single blood drop analyzer. The report also includes regulatory aspects, current and developing technologies, market projections and market share. An analysis of patents, clinical trials, innovations and opportunities, as well as the latest trends are also discussed. The report intends to explain the key trends of blood analysis technologies. It discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for the intended audience which includes blood analysis equipment manufacturers, POC device manufacturers, biochemical sensor manufacturers, angel investors, potential entrants and so forth. This study contributes to the areas of market growth among single blood drop analyzers and related technology manufacturers. Genomic research centers, academic institutions, government and private laboratories, various hospital settings as well as pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
In order to provide a better understanding of the market, the report is divided into segments based on applications, technology, end user, and geography. The technologies segment includes blood collection, blood analyzers, and consumable technologies; the applications section includes diagnostic testing for various diseases such as cancer, diabetes, cardiovascular, viral or bacterial infection, fertility, and allergy. Additionally, the report also focuses on patient monitoring and drug response monitoring. The report provides regional insight of leading market segments. Geographically, the global market is divided into North America, Europe, Asia-Pacific (APAC), and Rest of World. Further, the country-level market is analyzed according to its geographical region.
The report provides useful information to all the market players, potential entrants, government agencies and other interested parties. As the report also covers various geographic regions in detail, companies interested in expanding their geographic reach will also find the report useful.
REPORT INCLUDES:
The global single blood drop analysis market is expected to increase at a compound annual growth rate (CAGR) of REDACTED% and reach nearly $REDACTED billion during the 10-year forecast period of 2017 through 2027. Technological advancements are the major driving force for this market. Single blood drop analysis provides quality results which are similar to conventional lab testing. Single blood drop analysis is highlypopular in POC devices especially among diabetes patients for diagnosis and monitoring of bloodglucose. A number of leading players such as Bayer, Abbott, Alere, Siemens, Koninklijke Philips
Philips, and Becton Dickinson (BD) are already performing well in the diabetes care market. In the current market scenario, single blood drop analysis is not limited to diabetes testing and monitoring. A variety of tests can be performed on a single drop of blood. For example, i-STAT, a POC designed by Abbott can perform 26 tests by analyzing chemistries, electrolytes, hematology and blood gasses from single blood drop. Similarly, Toray Industries Inc. developed a test which can detect 13 types of cancers from a single blood drop. Cepheid, a Danaher company, developed a test which offers quantitative and qualitative assays for HIV, hepatitis C and Ebola by using three to four drops of blood. Karius Inc. developed a test that can identify 1,250 microbes (bacteria, viruses, fungi, protozoa) from a single drop of blood.
Presently, single blood drop tests are becoming more popular and attracting investors. In 2016, Genalyte, a startup engaged in single blood drop analysis, received $REDACTED million in funding. Additionally,1Drop Diagnostics received several investments from 2015 to 2017. During 2015, it received $REDACTED and in 2016, it received another $REDACTED from an undeclared source. With its testing kits, 1Dropfacilitates the early detection, prevention and management of disease, thus enabling individuals to livebetter lives. Theranos, once a popular and pioneering company in this market, received overall fundingof around $800 million. However, the company did not perform well in the market and failed. Thefailure of Theranos did not affect the growth of the market and many new players, mainly startups suchas Genalyte, Nueon Inc., 1Drop Diagnostics, GRAIL, Graphene Frontiers, Karius Inc., and Seventh SenseBiosystems have entered the market since. Apart from these new entrants, some well-establishedplayers such as Abbott, Philips, BD, Bayer, Roche, Siemens Healthcare, Danaher, and Alere are activelyparticipating in the mar ket to bring new technologies.
The scope of this study entails the current market for blood analyzers, especially the single blood drop analyzer. The report also includes regulatory aspects, current and developing technologies, market projections and market share. An analysis of patents, clinical trials, innovations and opportunities, as well as the latest trends are also discussed. The report intends to explain the key trends of blood analysis technologies. It discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for the intended audience which includes blood analysis equipment manufacturers, POC device manufacturers, biochemical sensor manufacturers, angel investors, potential entrants and so forth. This study contributes to the areas of market growth among single blood drop analyzers and related technology manufacturers. Genomic research centers, academic institutions, government and private laboratories, various hospital settings as well as pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
In order to provide a better understanding of the market, the report is divided into segments based on applications, technology, end user, and geography. The technologies segment includes blood collection, blood analyzers, and consumable technologies; the applications section includes diagnostic testing for various diseases such as cancer, diabetes, cardiovascular, viral or bacterial infection, fertility, and allergy. Additionally, the report also focuses on patient monitoring and drug response monitoring. The report provides regional insight of leading market segments. Geographically, the global market is divided into North America, Europe, Asia-Pacific (APAC), and Rest of World. Further, the country-level market is analyzed according to its geographical region.
The report provides useful information to all the market players, potential entrants, government agencies and other interested parties. As the report also covers various geographic regions in detail, companies interested in expanding their geographic reach will also find the report useful.
REPORT INCLUDES:
- 61 tables
- An overview of the global market for single blood drop analysis and its technologies
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Description of market trends and blood analysis tests and technologies
- Market breakdown by blood collection technologies, end use, application, and by region
- Discussion of new technologies in the market, and a patent analysis
- A look into key suppliers' and manufacturers' positioning and strategies
- Comprehensive company profiles of key players in the market, including Blusense Diagnostics, Koninklijke Philips, Siemens Healthcare, Toray Industries Inc., Abionic Sa, and 1drop Diagnostics
The global single blood drop analysis market is expected to increase at a compound annual growth rate (CAGR) of REDACTED% and reach nearly $REDACTED billion during the 10-year forecast period of 2017 through 2027. Technological advancements are the major driving force for this market. Single blood drop analysis provides quality results which are similar to conventional lab testing. Single blood drop analysis is highlypopular in POC devices especially among diabetes patients for diagnosis and monitoring of bloodglucose. A number of leading players such as Bayer, Abbott, Alere, Siemens, Koninklijke Philips
Philips, and Becton Dickinson (BD) are already performing well in the diabetes care market. In the current market scenario, single blood drop analysis is not limited to diabetes testing and monitoring. A variety of tests can be performed on a single drop of blood. For example, i-STAT, a POC designed by Abbott can perform 26 tests by analyzing chemistries, electrolytes, hematology and blood gasses from single blood drop. Similarly, Toray Industries Inc. developed a test which can detect 13 types of cancers from a single blood drop. Cepheid, a Danaher company, developed a test which offers quantitative and qualitative assays for HIV, hepatitis C and Ebola by using three to four drops of blood. Karius Inc. developed a test that can identify 1,250 microbes (bacteria, viruses, fungi, protozoa) from a single drop of blood.
Presently, single blood drop tests are becoming more popular and attracting investors. In 2016, Genalyte, a startup engaged in single blood drop analysis, received $REDACTED million in funding. Additionally,1Drop Diagnostics received several investments from 2015 to 2017. During 2015, it received $REDACTED and in 2016, it received another $REDACTED from an undeclared source. With its testing kits, 1Dropfacilitates the early detection, prevention and management of disease, thus enabling individuals to livebetter lives. Theranos, once a popular and pioneering company in this market, received overall fundingof around $800 million. However, the company did not perform well in the market and failed. Thefailure of Theranos did not affect the growth of the market and many new players, mainly startups suchas Genalyte, Nueon Inc., 1Drop Diagnostics, GRAIL, Graphene Frontiers, Karius Inc., and Seventh SenseBiosystems have entered the market since. Apart from these new entrants, some well-establishedplayers such as Abbott, Philips, BD, Bayer, Roche, Siemens Healthcare, Danaher, and Alere are activelyparticipating in the mar ket to bring new technologies.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Description of Market Trends
An Overview of Chemical and Biosensors
Chemical Sensors
Biosensors
Market Potential
Blood Analysis Testing and Technologies
Nucleic Acid Test
ELISA
Rapid Tests
Next Generation Sequencing
Western Blot Assay
Blood Analysis by Application
Key Favorable Factors in the Single Blood Drop Analysis Market: Increasing Prevalence of Diseases
Diagnosis of Multiple Diseases by Single-Drop Blood Testing
Disease Outbreaks
Funding and Aid
Cost Effectiveness
Advantage Over Conventional Methods
Rising New Method and Technology
Key Factors Hindering the Market Growth
Lack of Awareness
Less Accurate Methods
Rules and Regulations
Opportunity Analysis
Research and Development
Technology Advancements
Emerging Markets (Remote Areas)
CHAPTER 4 MARKET BREAKDOWN BY TECHNOLOGY
Blood Collection Technologies
Finger Prick
Capillary Puncture Method
Intravenous Blood Collection
Blood Analyzers
Point of Care Blood Analyzers
Lab-Based Blood Analyzers
Consumables
Reagents and Assays
Disposable Kits
CHAPTER 5 MARKET BREAKDOWN BY APPLICATION
Diagnosis
Cancer
Diabetes
Cardiology
Viral Bacterial Infections
Pregnancy Detection
Allergies
Patient Monitoring
Motivators
Drug Response
CHAPTER 6 MARKET BREAKDOWN BY END USER
Hospitals
Clinics
Individuals
Labs and Pathologies
R&D Organizations
CHAPTER 7 MARKET BREAKDOWN BY REGION
North America
Key Drivers
The U.S.
Canada
Asia-Pacific
Key Drivers
India
China
Japan
Europe
Key Drivers
The U.K.
Germany
France
Spain
Italy
Rest of World
Latin America
MENA
CHAPTER 8 PATENT REVIEW/ COMPETITIVE LANDSCAPE
Competitive Landscape
Patent Analysis
CHAPTER 9 COMPANY PROFILES
1DROP DIAGNOSTICS
ABBOTT
ABIONIC SA
ALERE
APOLLO MEDICAL DEVICES LLC
APOLLODX LLC
AVALUN SAS
BAYER AG
BECTON, DICKINSON AND COMPANY
BLUSENSE DIAGNOSTICS
CEPHEID
DNA e Group Holdings Ltd
EUROLYSER DIAGNOSTICA GMBH
GENALYTE INC.
GENTEEL LLC
GRAPHENE FRONTIERS
HICOMP MICROTECH CO. LTD.
HOME ACCESS HEALTH CORP.
HOWARD HUGHES MEDICAL INSTITUTE
I-CALQ LLC
IDEXX BIORESEARCH
INFORMED DATA SYSTEMS INC.
JANA CARE INC.
KARIUS INC.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
LIFESCAN
MAGARRAY INC.
MEDTRONIC PLC
NEOTERYX LLC
NOWDIAGNOSTICS
ORPHIDIA INC.
PIXCELL MEDICAL
PRENOSIS INC.
ROCHE DIAGNOSTICS
SEVENTH SENSE BIOSYSTEMS
SIEMENS HEALTHCARE
TELOMERE DIAGNOSTICS INC.
THERANOS
THRIVA LTD
TORAY INDUSTRIES INC.
VELANO VASCULAR INC.
ZEPTO LIFE TECHNOLOGY LLC
CHAPTER 10 APPENDIX PUBLISHED PATENTS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Description of Market Trends
An Overview of Chemical and Biosensors
Chemical Sensors
Biosensors
Market Potential
Blood Analysis Testing and Technologies
Nucleic Acid Test
ELISA
Rapid Tests
Next Generation Sequencing
Western Blot Assay
Blood Analysis by Application
Key Favorable Factors in the Single Blood Drop Analysis Market: Increasing Prevalence of Diseases
Diagnosis of Multiple Diseases by Single-Drop Blood Testing
Disease Outbreaks
Funding and Aid
Cost Effectiveness
Advantage Over Conventional Methods
Rising New Method and Technology
Key Factors Hindering the Market Growth
Lack of Awareness
Less Accurate Methods
Rules and Regulations
Opportunity Analysis
Research and Development
Technology Advancements
Emerging Markets (Remote Areas)
CHAPTER 4 MARKET BREAKDOWN BY TECHNOLOGY
Blood Collection Technologies
Finger Prick
Capillary Puncture Method
Intravenous Blood Collection
Blood Analyzers
Point of Care Blood Analyzers
Lab-Based Blood Analyzers
Consumables
Reagents and Assays
Disposable Kits
CHAPTER 5 MARKET BREAKDOWN BY APPLICATION
Diagnosis
Cancer
Diabetes
Cardiology
Viral Bacterial Infections
Pregnancy Detection
Allergies
Patient Monitoring
Motivators
Drug Response
CHAPTER 6 MARKET BREAKDOWN BY END USER
Hospitals
Clinics
Individuals
Labs and Pathologies
R&D Organizations
CHAPTER 7 MARKET BREAKDOWN BY REGION
North America
Key Drivers
The U.S.
Canada
Asia-Pacific
Key Drivers
India
China
Japan
Europe
Key Drivers
The U.K.
Germany
France
Spain
Italy
Rest of World
Latin America
MENA
CHAPTER 8 PATENT REVIEW/ COMPETITIVE LANDSCAPE
Competitive Landscape
Patent Analysis
CHAPTER 9 COMPANY PROFILES
1DROP DIAGNOSTICS
ABBOTT
ABIONIC SA
ALERE
APOLLO MEDICAL DEVICES LLC
APOLLODX LLC
AVALUN SAS
BAYER AG
BECTON, DICKINSON AND COMPANY
BLUSENSE DIAGNOSTICS
CEPHEID
DNA e Group Holdings Ltd
EUROLYSER DIAGNOSTICA GMBH
GENALYTE INC.
GENTEEL LLC
GRAPHENE FRONTIERS
HICOMP MICROTECH CO. LTD.
HOME ACCESS HEALTH CORP.
HOWARD HUGHES MEDICAL INSTITUTE
I-CALQ LLC
IDEXX BIORESEARCH
INFORMED DATA SYSTEMS INC.
JANA CARE INC.
KARIUS INC.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
LIFESCAN
MAGARRAY INC.
MEDTRONIC PLC
NEOTERYX LLC
NOWDIAGNOSTICS
ORPHIDIA INC.
PIXCELL MEDICAL
PRENOSIS INC.
ROCHE DIAGNOSTICS
SEVENTH SENSE BIOSYSTEMS
SIEMENS HEALTHCARE
TELOMERE DIAGNOSTICS INC.
THERANOS
THRIVA LTD
TORAY INDUSTRIES INC.
VELANO VASCULAR INC.
ZEPTO LIFE TECHNOLOGY LLC
CHAPTER 10 APPENDIX PUBLISHED PATENTS
LIST OF TABLES
Summary Table: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Table 1: Advantages and Disadvantages of Chemical Fibrosensors
Table 2: Advantages and Limitations of Noninvasive Blood Gas Monitoring Sensor
Table 3: Characteristics of Microorganism-Based Sensors
Table 4: Several Microbial Sensors and Its Description
Table 5: Applications of Biosensor in Healthcare
Table 6: Results Seen with Lyme Disease Antibody Tests
Table 7: Point of Care Diagnostic Devices
Table 8: Global Diabetes Prevalence,2014
Table 9: Product Range of Cholesterol Blood Test
Table 10: Commercialized CGM Sensors
Table 11: Physicians Per 1,000 Population,2011-2014
Table 12: Glucose Concentrations for Precision Evaluations
Table 13: Tuberculosis (TB) Cases by Incidence and Mortality, by Region, 2016
Table 14: Global Market for Single Blood Drop Analysis by Technology, Through 2027
Table 15: Global Market for Single-Blood Drop Analysis by Blood Collection Technology, Through 2027
Table 16: Finger Prick Method Versus Venous Blood Samples
Table 17: Global Market for Single Blood Drop Analysis for Blood Analyzer Technology, by Type, Through 2027
Table 18: Global Market for Single Blood Drop Analysis for Consumables, by Type, Through 2027
Table 19: Prices of Some Blood Glucose Monitoring Test Strips, 2017
Table 20: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Table 21: Global Market for Single Blood Drop Analysis for Diagnosis, by Type, Through 2027
Table 22: Global Market for Single Blood Drop Analysis for Cancer, by Region, Through 2027
Table 23: Global Market for Single Blood Drop Analysis for Diabetes, by Region, Through 2027
Table 24: Global Market for Single Blood Drop Analysis for Cardiology, by Region, Through 2027
Table 25: Global Market for Single Blood Drop Analysis for Viral/Bacterial Infections, by Region, Through 2027
Table 26: Global Market for Single Blood Drop Analysis for Pregnancy Detection, by Region, Through 2027
Table 27: Global Market for Single Blood Drop Analysis for Allergies, by Region, Through 2027
Table 28: Global Market for Single Blood Drop Analysis for Patient Monitoring, by Region, Through 2027
Table 29: Global Market for Single Blood Drop Analysis for Drug Response, by Region, Through 2027
Table 30: Global Market for Single Blood Drop Analysis by End User, Through 2027
Table 31: Global Market for Single Blood Drop Analysis for Hospitals, by Region, Through 2027
Table 32: Global Market for Single Blood Drop Analysis for Clinics, by Region, Through 2027
Table 33: Global Market for Single Blood Drop Analysis for Individuals, by Region, Through 2027
Table 34: Global Market for Single Blood Drop Analysis for Lab and Pathologies, by Region, Through 2027
Table 35: Global Market for Single Blood Drop Analysis for R&D Organizations, by Region, Through 2027
Table 36: Global Market for Single Blood Drop Analysis, by Region, Through 2027
Table 37: North American Market for Single Blood Drop Analysis, by Application, Through 2027
Table 38: North American Market for Single Blood Drop Analysis, by End User, Through 2027
Table 39: North American Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 40: North American Market for Single Blood Drop Analysis, by Country, Through 2027
Table 41: Key Statistics of Diabetes Prevalence in Canada
Table 42: APAC Market for Single Blood Drop Analysis, by Application, Through 2027
Table 43: APAC Market for Single Blood Drop Analysis, by End User, Through 2027
Table 44: APAC Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 45: APAC Market for Single Blood Drop Analysis, by Country, Through 2027
Table 46: European Market for Single Blood Drop Analysis, by Application, Through 2027
Table 47: European Market for Single Blood Drop Analysis, by End User, Through 2027
Table 48: European Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 49: European Market for Single Blood Drop Analysis, by Country, Through 2027
Table 50: Number of People Diagnosed with Diabetes in the Adult Population,2016
Table 51: Rest of the World Market for Single Blood Drop Analysis, by Application, Through 2027
Table 52: Rest of the World Market for Single Blood Drop Analysis, by End User, Through 2027
Table 53: Rest of the World Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 54: Rest of the World Market for Single Blood Drop Analysis, by Country, Through 2027
Table 55: Key Acquisitions in the Single Blood Drop Analysis Technology Industry
Table 56: Approved Products for the Single Blood Drop Analysis Technology Industry
Table 57: Partnership and Collaboration in the Single Blood Drop Analysis Technology Industry
Table 58: Patent for Single Blood Drop Analysis, by Technology
Table 59: Patent for Single Blood Drop Analysis, by Assignee
Table 60: Patents for Single Blood Drop Analysis, by Patent Office
Table 61: List of Published Patents, Jan 2015-Nov 2017
Summary Table: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Table 1: Advantages and Disadvantages of Chemical Fibrosensors
Table 2: Advantages and Limitations of Noninvasive Blood Gas Monitoring Sensor
Table 3: Characteristics of Microorganism-Based Sensors
Table 4: Several Microbial Sensors and Its Description
Table 5: Applications of Biosensor in Healthcare
Table 6: Results Seen with Lyme Disease Antibody Tests
Table 7: Point of Care Diagnostic Devices
Table 8: Global Diabetes Prevalence,2014
Table 9: Product Range of Cholesterol Blood Test
Table 10: Commercialized CGM Sensors
Table 11: Physicians Per 1,000 Population,2011-2014
Table 12: Glucose Concentrations for Precision Evaluations
Table 13: Tuberculosis (TB) Cases by Incidence and Mortality, by Region, 2016
Table 14: Global Market for Single Blood Drop Analysis by Technology, Through 2027
Table 15: Global Market for Single-Blood Drop Analysis by Blood Collection Technology, Through 2027
Table 16: Finger Prick Method Versus Venous Blood Samples
Table 17: Global Market for Single Blood Drop Analysis for Blood Analyzer Technology, by Type, Through 2027
Table 18: Global Market for Single Blood Drop Analysis for Consumables, by Type, Through 2027
Table 19: Prices of Some Blood Glucose Monitoring Test Strips, 2017
Table 20: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Table 21: Global Market for Single Blood Drop Analysis for Diagnosis, by Type, Through 2027
Table 22: Global Market for Single Blood Drop Analysis for Cancer, by Region, Through 2027
Table 23: Global Market for Single Blood Drop Analysis for Diabetes, by Region, Through 2027
Table 24: Global Market for Single Blood Drop Analysis for Cardiology, by Region, Through 2027
Table 25: Global Market for Single Blood Drop Analysis for Viral/Bacterial Infections, by Region, Through 2027
Table 26: Global Market for Single Blood Drop Analysis for Pregnancy Detection, by Region, Through 2027
Table 27: Global Market for Single Blood Drop Analysis for Allergies, by Region, Through 2027
Table 28: Global Market for Single Blood Drop Analysis for Patient Monitoring, by Region, Through 2027
Table 29: Global Market for Single Blood Drop Analysis for Drug Response, by Region, Through 2027
Table 30: Global Market for Single Blood Drop Analysis by End User, Through 2027
Table 31: Global Market for Single Blood Drop Analysis for Hospitals, by Region, Through 2027
Table 32: Global Market for Single Blood Drop Analysis for Clinics, by Region, Through 2027
Table 33: Global Market for Single Blood Drop Analysis for Individuals, by Region, Through 2027
Table 34: Global Market for Single Blood Drop Analysis for Lab and Pathologies, by Region, Through 2027
Table 35: Global Market for Single Blood Drop Analysis for R&D Organizations, by Region, Through 2027
Table 36: Global Market for Single Blood Drop Analysis, by Region, Through 2027
Table 37: North American Market for Single Blood Drop Analysis, by Application, Through 2027
Table 38: North American Market for Single Blood Drop Analysis, by End User, Through 2027
Table 39: North American Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 40: North American Market for Single Blood Drop Analysis, by Country, Through 2027
Table 41: Key Statistics of Diabetes Prevalence in Canada
Table 42: APAC Market for Single Blood Drop Analysis, by Application, Through 2027
Table 43: APAC Market for Single Blood Drop Analysis, by End User, Through 2027
Table 44: APAC Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 45: APAC Market for Single Blood Drop Analysis, by Country, Through 2027
Table 46: European Market for Single Blood Drop Analysis, by Application, Through 2027
Table 47: European Market for Single Blood Drop Analysis, by End User, Through 2027
Table 48: European Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 49: European Market for Single Blood Drop Analysis, by Country, Through 2027
Table 50: Number of People Diagnosed with Diabetes in the Adult Population,2016
Table 51: Rest of the World Market for Single Blood Drop Analysis, by Application, Through 2027
Table 52: Rest of the World Market for Single Blood Drop Analysis, by End User, Through 2027
Table 53: Rest of the World Market for Single Blood Drop Analysis, by Technology, Through 2027
Table 54: Rest of the World Market for Single Blood Drop Analysis, by Country, Through 2027
Table 55: Key Acquisitions in the Single Blood Drop Analysis Technology Industry
Table 56: Approved Products for the Single Blood Drop Analysis Technology Industry
Table 57: Partnership and Collaboration in the Single Blood Drop Analysis Technology Industry
Table 58: Patent for Single Blood Drop Analysis, by Technology
Table 59: Patent for Single Blood Drop Analysis, by Assignee
Table 60: Patents for Single Blood Drop Analysis, by Patent Office
Table 61: List of Published Patents, Jan 2015-Nov 2017
LIST OF FIGURES
Summary Figure: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Figure 1: Chemical Sensors Contain Two Basic Functional Units
Figure 2: Types of Biosensors Used in the Biomedical Element Recognition Process
Figure 3: Global Instance of HIV, 2016
Figure 4: Global Prevalence and Treatment of HIV, 2013-2016
Figure 5: Cumulative Prevalence of Zika Virus (Until May 2017)
Figure 6: Rural Population,2016
Figure 7: Point of Care Diagnostics as an Integrated Process
Figure 8: Market motivators for the POCT devices
Figure 9: Estimated Age-adjusted Prevalence of Diagnosed Diabetes by Race/Ethnicity and Sex Among Adults Aged ?18 Years, the U.S., 2013–2015
Figure 10: Japanese Cancer Prevalence Rate (Both Male and Female), 2010-2015 (per 100,000 people)
COMPANIES MENTIONED
1DROP DIAGNOSTICS
ABBOTT
ABIONIC SA
ALERE
APOLLO MEDICAL DEVICES LLC
APOLLODX LLC
AVALUN SAS
BAYER AG
BECTON, DICKINSON AND COMPANY
BLUSENSE DIAGNOSTICS
CEPHEID
DNA e Group Holdings Ltd
EUROLYSER DIAGNOSTICA GMBH
GENALYTE INC.
GENTEEL LLC
GRAPHENE FRONTIERS
HICOMP MICROTECH CO. LTD.
HOME ACCESS HEALTH CORP.
HOWARD HUGHES MEDICAL INSTITUTE
I-CALQ LLC
IDEXX BIORESEARCH
INFORMED DATA SYSTEMS INC.
JANA CARE INC.
KARIUS INC.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
LIFESCAN
MAGARRAY INC.
MEDTRONIC PLC
NEOTERYX LLC
NOWDIAGNOSTICS
ORPHIDIA INC.
PIXCELL MEDICAL
PRENOSIS INC.
ROCHE DIAGNOSTICS
SEVENTH SENSE BIOSYSTEMS
SIEMENS HEALTHCARE
TELOMERE DIAGNOSTICS INC.
THERANOS
THRIVA LTD
TORAY INDUSTRIES INC.
VELANO VASCULAR INC.
ZEPTO LIFE TECHNOLOGY LLC
Summary Figure: Global Market for Single Blood Drop Analysis, by Application, Through 2027
Figure 1: Chemical Sensors Contain Two Basic Functional Units
Figure 2: Types of Biosensors Used in the Biomedical Element Recognition Process
Figure 3: Global Instance of HIV, 2016
Figure 4: Global Prevalence and Treatment of HIV, 2013-2016
Figure 5: Cumulative Prevalence of Zika Virus (Until May 2017)
Figure 6: Rural Population,2016
Figure 7: Point of Care Diagnostics as an Integrated Process
Figure 8: Market motivators for the POCT devices
Figure 9: Estimated Age-adjusted Prevalence of Diagnosed Diabetes by Race/Ethnicity and Sex Among Adults Aged ?18 Years, the U.S., 2013–2015
Figure 10: Japanese Cancer Prevalence Rate (Both Male and Female), 2010-2015 (per 100,000 people)
COMPANIES MENTIONED
1DROP DIAGNOSTICS
ABBOTT
ABIONIC SA
ALERE
APOLLO MEDICAL DEVICES LLC
APOLLODX LLC
AVALUN SAS
BAYER AG
BECTON, DICKINSON AND COMPANY
BLUSENSE DIAGNOSTICS
CEPHEID
DNA e Group Holdings Ltd
EUROLYSER DIAGNOSTICA GMBH
GENALYTE INC.
GENTEEL LLC
GRAPHENE FRONTIERS
HICOMP MICROTECH CO. LTD.
HOME ACCESS HEALTH CORP.
HOWARD HUGHES MEDICAL INSTITUTE
I-CALQ LLC
IDEXX BIORESEARCH
INFORMED DATA SYSTEMS INC.
JANA CARE INC.
KARIUS INC.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
LIFESCAN
MAGARRAY INC.
MEDTRONIC PLC
NEOTERYX LLC
NOWDIAGNOSTICS
ORPHIDIA INC.
PIXCELL MEDICAL
PRENOSIS INC.
ROCHE DIAGNOSTICS
SEVENTH SENSE BIOSYSTEMS
SIEMENS HEALTHCARE
TELOMERE DIAGNOSTICS INC.
THERANOS
THRIVA LTD
TORAY INDUSTRIES INC.
VELANO VASCULAR INC.
ZEPTO LIFE TECHNOLOGY LLC